three-dimensional positioning angle. We report the results of this prospective series.
University of Queensland and The Prince Charles Hospital, Australia
Background and Aims: Bacterial colonisation of the airways frequently complicates chronic obstructive pulmonary disease (COPD). We hypothesised that microbial over-abundance and dysbiosis in airways of patients with COPD would correlate with excessive airway inflammation.
Methods: Patients were recruited during exacerbation or stability from a tertiary referral hospital. Spontaneously-produced sputum was tested using conventional culture, quantitative PCR (qPCR) for 48 bacterial and fungal targets (QIAGEN), 16S rRNA sequencing for the bacterial microbiome, and NanoString gene expression (inflammation array, 249 targets).
Results: 61 patients (37 exacerbation, 24 stable) were recruited (31 male, 30 female, mean age 69 years, FEV1 49% predicted, mean smoking history 42 pack-years). Exacerbation patients had reduced quality of life and more purulent sputum, compared with stable patients. qPCR detected bacterial and fungal species in 95% of sputum samples, versus 43% with culture, with no statistically significant difference in microbial load between exacerbation and stability. NanoString inflammatory gene expression analysis showed decreased HLA-DRB1 (fold change 0.44, P < 0.001) mRNA expression in the exacerbation cohort compared to stable. Patients with qPCR-detected Streptococcus pneumoniae in sputum (80% of patients) showed increased sputum expression of CXCL1 (foldchange 2.3, P = 0.006), whereas presence of Prevotella oris (36% of patients) was associated with reduced expression of AREG (fold-change 0.47, P = 0.003) and NLRP3 (fold-change 0.55, P = 0.012). Sputum microbial richness and diversity, as determined by 16S rRNA sequencing, were not statistically significantly different between exacerbation and stable patients.
Conclusion: COPD patients during exacerbation had similar numbers of bacterial species compared to stable patients, as detected by qPCR or culture. Inflammatory gene expression analysis demonstrated bacterial species-specific patterns of inflammatory mediators in sputum.
No difference in microbial richness or diversity was detected in the sputum of exacerbation and stable patients. Identification of bacterial species-specific interactions with airway inflammatory profiles may help better understand the heterogeneity of COPD and to personalise management. Methods: By using next-generation sequencing (NGS), we examined the expression profiles of microRNAs and mRNAs of normal and COPD bronchial epithelial cells. The criteria for microRNAs selection were foldchange >2, and reads per million (RPM) > 1. miRmap database, miRDB database, and TargetScan database were used for predicting the possible miRNA-mRNA interaction. Gene expression omnibus (GEO) database was used to confirm the gene expression in previous studies.
Results: 4 genes with microRNA-mRNA interactions involving in COPD small airway bronchial epithelial cells were identified in this study, including NT5E, SDK1, TNS1, and PCDH7. The significant change of miR-6511a-5p/NT5E interaction was found in small airway bronchial epithelial cells, large airway bronchial epithelial cells, and alveolar macrophage. It implies that miR-6511a-5p/NT5E interaction may be an important factor in COPD. Through bioinformatics, we demonstrated that miR-6511a-5p/NT5E may be associated with the cell-cell contact, activation of leukocytes, activation of T lymphocytes, and cellular homeostasis. 
